There are 412 resources available
Q&A and discussion
Session: Clinical trials design: Novel designs
Resources:
Webcast
Q&A and discussion
Session: Post neoadjuvant systemic treatment decisions
Resources:
Webcast
Q&A and discussion
Session: Practice changes based on real-world data
Resources:
Webcast
Introduction by the Chair
Presenter: Suzette Delaloge
Session: Keynote lecture 2
Resources:
Slides
Webcast
Evolutionary histories of breast cancer and related clones
Presenter: Tomomi Nishimura
Session: Keynote lecture 2
Resources:
Slides
Webcast
179O - Combination of olaparib, durvalumab and fulvestrant in patients with advanced ER-positive, HER2-negative breast cancer harboring homologous recombination repair (HRR) deficiency or microsatellite instability (MSI): Results of the international phase II DOLAF trial
Presenter: Séverine Guiu
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
Individual tailoring of risk assessment for germline variants beyond BRCA
Presenter: Kelly-Anne Phillips
Session: Actionability of germline variants beyond BRCA 1 and 2
Resources:
Slides
Webcast
Challenges and opportunities for biomarker research in the pre-operative setting
Presenter: Laura Van't Veer
Session: Biomarkers-based treatment decision for early and metastatic breast cancer
Resources:
Slides
Webcast
180O - IMpassion132 double-blind randomised phase III trial of chemotherapy (CT) ± atezolizumab (atezo) for early-relapsing unresectable locally advanced or metastatic triple-negative breast cancer (aTNBC)
Presenter: Rebecca Dent
Session: Proffered Paper session 1
Resources:
Abstract
Slides
Webcast
BRCA1/2 and beyond: The surgeons perspective
Presenter: Peter Dubsky
Session: Actionability of germline variants beyond BRCA 1 and 2
Resources:
Slides
Webcast